Toppgene analysis for Wikipedia protein communities, toppgene analysis, cc306_6, positive side

Go To Start Page
Input Parameters [Show Detail]
Training Results [Expand All] [Download All] [Sparse Matrix]
Display pValues and Scores as Table row limit

1: GO: Molecular Function [Display Chart] 6 input genes in category / 43 annotations before applied cutoff / 18661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0043183 vascular endothelial growth factor receptor 1 binding 8.615E-8 3.705E-6 1.612E-5 3.705E-6 2 2
2 GO:0005172 vascular endothelial growth factor receptor binding 6.709E-6 1.443E-4 6.275E-4 2.885E-4 2 13
3 GO:0042056 chemoattractant activity 3.484E-5 4.994E-4 2.173E-3 1.498E-3 2 29
4 GO:0005126 cytokine receptor binding 7.103E-5 7.635E-4 3.321E-3 3.054E-3 3 289
5 GO:0070851 growth factor receptor binding 8.572E-4 7.164E-3 3.117E-2 3.686E-2 2 143
6 GO:0008083 growth factor activity 1.152E-3 7.164E-3 3.117E-2 4.956E-2 2 166
7 GO:0008201 heparin binding 1.166E-3 7.164E-3 3.117E-2
5.015E-2
 2 167
8 GO:0005539 glycosaminoglycan binding 1.994E-3 9.670E-3 4.207E-2
8.573E-2
 2 219
9 GO:0005168 neurotrophin TRKA receptor binding 2.249E-3 9.670E-3 4.207E-2
9.670E-2
 1 7
10 GO:0043184 vascular endothelial growth factor receptor 2 binding 2.249E-3 9.670E-3 4.207E-2
9.670E-2
 1 7
11 GO:0005167 neurotrophin TRK receptor binding 2.570E-3 1.002E-2 4.357E-2
1.105E-1
 1 8
12 GO:1901681 sulfur compound binding 2.795E-3 1.002E-2 4.357E-2
1.202E-1
 2 260
13 GO:0000774 adenyl-nucleotide exchange factor activity 3.211E-3 1.062E-2 4.621E-2
1.381E-1
 1 10
14 GO:0005165 neurotrophin receptor binding 4.494E-3 1.380E-2
6.001E-2
1.932E-1
 1 14
15 GO:0038191 neuropilin binding 4.814E-3 1.380E-2
6.001E-2
2.070E-1
 1 15
16 GO:0048018 receptor ligand activity 5.454E-3 1.380E-2
6.001E-2
2.345E-1
 1 17
17 GO:0005161 platelet-derived growth factor receptor binding 5.454E-3 1.380E-2
6.001E-2
2.345E-1
 1 17
18 GO:0004435 phosphatidylinositol phospholipase C activity 8.970E-3 2.143E-2
9.322E-2
3.857E-1
 1 28
19 GO:0060590 ATPase regulator activity 1.025E-2 2.190E-2
9.524E-2
4.406E-1
 1 32
20 GO:0001968 fibronectin binding 1.056E-2 2.190E-2
9.524E-2
4.543E-1
 1 33
21 GO:0005158 insulin receptor binding 1.088E-2 2.190E-2
9.524E-2
4.680E-1
 1 34
22 GO:0030546 receptor activator activity 1.120E-2 2.190E-2
9.524E-2
4.817E-1
 1 35
23 GO:0004629 phospholipase C activity 1.184E-2 2.213E-2
9.628E-2
5.091E-1
 1 37
24 GO:0035254 glutamate receptor binding 1.470E-2 2.634E-2
1.146E-1
6.322E-1
 1 46
25 GO:0030545 receptor regulator activity 1.629E-2 2.802E-2
1.219E-1
7.004E-1
 1 51
26 GO:0050840 extracellular matrix binding 1.787E-2 2.956E-2
1.286E-1
7.686E-1
 1 56
27 GO:0030971 receptor tyrosine kinase binding 1.914E-2 3.048E-2
1.326E-1
8.230E-1
 1 60
28 GO:1990782 protein tyrosine kinase binding 2.104E-2 3.231E-2
1.405E-1
9.046E-1
 1 66
29 GO:0051219 phosphoprotein binding 2.482E-2 3.680E-2
1.601E-1
1.000E0
 1 78
30 GO:0051087 chaperone binding 2.608E-2 3.738E-2
1.626E-1
1.000E0
 1 82
31 GO:0004867 serine-type endopeptidase inhibitor activity 3.048E-2 4.179E-2
1.818E-1
1.000E0
 1 96
32 GO:0008081 phosphoric diester hydrolase activity 3.110E-2 4.179E-2
1.818E-1
1.000E0
 1 98
Show 27 more annotations

2: GO: Biological Process [Display Chart] 6 input genes in category / 648 annotations before applied cutoff / 18623 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0045765 regulation of angiogenesis 3.889E-7 1.876E-4 1.323E-3 2.520E-4 4 239
2 GO:1901342 regulation of vasculature development 5.791E-7 1.876E-4 1.323E-3 3.753E-4 4 264
3 GO:0060754 positive regulation of mast cell chemotaxis 1.297E-6 2.801E-4 1.975E-3 8.404E-4 2 6
4 GO:0060753 regulation of mast cell chemotaxis 1.815E-6 2.941E-4 2.074E-3 1.176E-3 2 7
5 GO:0010594 regulation of endothelial cell migration 5.017E-6 5.594E-4 3.945E-3 3.251E-3 3 119
6 GO:0001525 angiogenesis 5.485E-6 5.594E-4 3.945E-3 3.554E-3 4 464
7 GO:0002551 mast cell chemotaxis 6.737E-6 5.594E-4 3.945E-3 4.365E-3 2 13
8 GO:0045766 positive regulation of angiogenesis 7.011E-6 5.594E-4 3.945E-3 4.543E-3 3 133
9 GO:0043117 positive regulation of vascular permeability 7.859E-6 5.594E-4 3.945E-3 5.092E-3 2 14
10 GO:0097531 mast cell migration 9.066E-6 5.594E-4 3.945E-3 5.875E-3 2 15
11 GO:1904018 positive regulation of vasculature development 9.864E-6 5.594E-4 3.945E-3 6.392E-3 3 149
12 GO:0050930 induction of positive chemotaxis 1.036E-5 5.594E-4 3.945E-3 6.713E-3 2 16
13 GO:0043542 endothelial cell migration 1.315E-5 6.556E-4 4.623E-3 8.523E-3 3 164
14 GO:0010632 regulation of epithelial cell migration 1.598E-5 7.082E-4 4.994E-3 1.035E-2 3 175
15 GO:0030949 positive regulation of vascular endothelial growth factor receptor signaling pathway 1.639E-5 7.082E-4 4.994E-3 1.062E-2 2 20
16 GO:1901215 negative regulation of neuron death 2.528E-5 1.024E-3 7.221E-3 1.638E-2 3 204
17 GO:0043536 positive regulation of blood vessel endothelial cell migration 3.025E-5 1.153E-3 8.133E-3 1.961E-2 2 27
18 GO:0050927 positive regulation of positive chemotaxis 3.258E-5 1.173E-3 8.270E-3 2.111E-2 2 28
19 GO:0050926 regulation of positive chemotaxis 3.499E-5 1.193E-3 8.414E-3 2.267E-2 2 29
20 GO:0010631 epithelial cell migration 3.858E-5 1.216E-3 8.575E-3 2.500E-2 3 235
21 GO:0090132 epithelium migration 4.007E-5 1.216E-3 8.575E-3 2.596E-2 3 238
22 GO:0030947 regulation of vascular endothelial growth factor receptor signaling pathway 4.272E-5 1.216E-3 8.575E-3 2.768E-2 2 32
23 GO:0090130 tissue migration 4.316E-5 1.216E-3 8.575E-3 2.797E-2 3 244
24 GO:0043114 regulation of vascular permeability 5.123E-5 1.383E-3 9.754E-3 3.320E-2 2 35
25 GO:1901214 regulation of neuron death 8.552E-5 2.217E-3 1.563E-2
5.542E-2
 3 307
26 GO:0050678 regulation of epithelial cell proliferation 9.945E-5 2.479E-3 1.748E-2
6.445E-2
 3 323
27 GO:0070997 neuron death 1.220E-4 2.749E-3 1.939E-2
7.904E-2
 3 346
28 GO:0043535 regulation of blood vessel endothelial cell migration 1.229E-4 2.749E-3 1.939E-2
7.962E-2
 2 54
29 GO:0001667 ameboidal-type cell migration 1.230E-4 2.749E-3 1.939E-2
7.972E-2
 3 347
30 GO:0050918 positive chemotaxis 1.468E-4 3.171E-3 2.236E-2
9.513E-2
 2 59
31 GO:0050900 leukocyte migration 1.687E-4 3.526E-3 2.487E-2
1.093E-1
 3 386
32 GO:0050673 epithelial cell proliferation 1.752E-4 3.549E-3 2.502E-2
1.136E-1
 3 391
33 GO:0060976 coronary vasculature development 2.010E-4 3.941E-3 2.779E-2
1.303E-1
 2 69
34 GO:0010595 positive regulation of endothelial cell migration 2.129E-4 3.941E-3 2.779E-2
1.379E-1
 2 71
35 GO:0001938 positive regulation of endothelial cell proliferation 2.129E-4 3.941E-3 2.779E-2
1.379E-1
 2 71
36 GO:0030335 positive regulation of cell migration 2.569E-4 4.500E-3 3.174E-2
1.665E-1
 3 445
37 GO:0043534 blood vessel endothelial cell migration 2.570E-4 4.500E-3 3.174E-2
1.665E-1
 2 78
38 GO:2000147 positive regulation of cell motility 2.797E-4 4.639E-3 3.272E-2
1.812E-1
 3 458
39 GO:0051272 positive regulation of cellular component movement 3.018E-4 4.639E-3 3.272E-2
1.956E-1
 3 470
40 GO:0002690 positive regulation of leukocyte chemotaxis 3.124E-4 4.639E-3 3.272E-2
2.024E-1
 2 86
41 GO:0040017 positive regulation of locomotion 3.153E-4 4.639E-3 3.272E-2
2.043E-1
 3 477
42 GO:0018400 peptidyl-proline hydroxylation to 3-hydroxy-L-proline 3.222E-4 4.639E-3 3.272E-2
2.088E-1
 1 1
43 GO:1903570 regulation of protein kinase D signaling 3.222E-4 4.639E-3 3.272E-2
2.088E-1
 1 1
44 GO:1903572 positive regulation of protein kinase D signaling 3.222E-4 4.639E-3 3.272E-2
2.088E-1
 1 1
45 GO:0002575 basophil chemotaxis 3.222E-4 4.639E-3 3.272E-2
2.088E-1
 1 1
46 GO:0051897 positive regulation of protein kinase B signaling 3.346E-4 4.713E-3 3.323E-2
2.168E-1
 2 89
47 GO:0048010 vascular endothelial growth factor receptor signaling pathway 4.055E-4 5.591E-3 3.943E-2
2.628E-1
 2 98
48 GO:0001936 regulation of endothelial cell proliferation 4.479E-4 6.046E-3 4.264E-2
2.902E-1
 2 103
49 GO:0002576 platelet degranulation 4.832E-4 6.263E-3 4.416E-2
3.131E-1
 2 107
50 GO:0002688 regulation of leukocyte chemotaxis 4.832E-4 6.263E-3 4.416E-2
3.131E-1
 2 107
Show 45 more annotations

3: GO: Cellular Component [Display Chart] 6 input genes in category / 25 annotations before applied cutoff / 19061 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0031093 platelet alpha granule lumen 1.217E-4 1.710E-3 6.525E-3 3.043E-3 2 55
2 GO:0031091 platelet alpha granule 2.268E-4 1.710E-3 6.525E-3 5.670E-3 2 75
3 GO:0031012 extracellular matrix 2.383E-4 1.710E-3 6.525E-3 5.957E-3 3 444
4 GO:0034774 secretory granule lumen 2.914E-4 1.710E-3 6.525E-3 7.285E-3 2 85
5 GO:0060205 cytoplasmic vesicle lumen 4.360E-4 1.710E-3 6.525E-3 1.090E-2 2 104
6 GO:0031983 vesicle lumen 4.701E-4 1.710E-3 6.525E-3 1.175E-2 2 108
7 GO:0005604 basement membrane 4.788E-4 1.710E-3 6.525E-3 1.197E-2 2 109
8 GO:0044420 extracellular matrix component 7.993E-4 2.498E-3 9.532E-3 1.998E-2 2 141
9 GO:0043203 axon hillock 2.516E-3 6.989E-3 2.667E-2
6.290E-2
 1 8
10 GO:0030141 secretory granule 6.231E-3 1.558E-2
5.944E-2
1.558E-1
 2 400
11 GO:0008180 COP9 signalosome 1.066E-2 2.422E-2
9.242E-2
2.664E-1
 1 34
Show 6 more annotations

4: Human Phenotype [Display Chart] 3 input genes in category / 193 annotations before applied cutoff / 4707 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 HP:0003321 Biconcave flattened vertebrae 1.218E-5 8.791E-4 5.136E-3 2.350E-3 2 10
2 HP:0005005 Femoral bowing present at birth, straightening with time 1.218E-5 8.791E-4 5.136E-3 2.350E-3 2 10
3 HP:0005897 Severe generalized osteoporosis 1.785E-5 8.791E-4 5.136E-3 3.445E-3 2 12
4 HP:0005758 Basilar impression 2.109E-5 8.791E-4 5.136E-3 4.071E-3 2 13
5 HP:0003023 Bowing of limbs due to multiple fractures 2.461E-5 8.791E-4 5.136E-3 4.749E-3 2 14
6 HP:0005474 Decreased calvarial ossification 3.244E-5 8.791E-4 5.136E-3 6.261E-3 2 16
7 HP:0000362 Otosclerosis 3.676E-5 8.791E-4 5.136E-3 7.095E-3 2 17
8 HP:0005855 Multiple prenatal fractures 3.676E-5 8.791E-4 5.136E-3 7.095E-3 2 17
9 HP:0003179 Protrusio acetabuli 4.135E-5 8.791E-4 5.136E-3 7.980E-3 2 18
10 HP:0008921 Neonatal short-limb short stature 5.133E-5 8.791E-4 5.136E-3 9.907E-3 2 20
11 HP:0002699 Abnormality of the foramen magnum 5.673E-5 8.791E-4 5.136E-3 1.095E-2 2 21
12 HP:0010299 Abnormality of dentin 6.239E-5 8.791E-4 5.136E-3 1.204E-2 2 22
13 HP:0000703 Dentinogenesis imperfecta 6.239E-5 8.791E-4 5.136E-3 1.204E-2 2 22
14 HP:0002691 Platybasia 6.833E-5 8.791E-4 5.136E-3 1.319E-2 2 23
15 HP:0008628 Abnormality of the stapes 6.833E-5 8.791E-4 5.136E-3 1.319E-2 2 23
16 HP:0003505 Short limb dwarfism 8.100E-5 9.770E-4 5.708E-3 1.563E-2 2 25
17 HP:0001516 Dwarfism 8.773E-5 9.960E-4 5.819E-3 1.693E-2 2 26
18 HP:0040160 Generalized osteoporosis 9.474E-5 1.016E-3 5.935E-3 1.828E-2 2 27
19 HP:0004452 Abnormality of the middle ear ossicles 1.020E-4 1.036E-3 6.054E-3 1.969E-2 2 28
20 HP:0004586 Biconcave vertebral bodies 1.096E-4 1.057E-3 6.176E-3 2.114E-2 2 29
21 HP:0004331 Decreased skull ossification 1.424E-4 1.309E-3 7.646E-3 2.748E-2 2 33
22 HP:0008609 Morphological abnormality of the middle ear 1.604E-4 1.407E-3 8.222E-3 3.096E-2 2 35
23 HP:0002982 Tibial bowing 1.997E-4 1.675E-3 9.789E-3 3.853E-2 2 39
24 HP:0002953 Vertebral compression fractures 2.432E-4 1.956E-3 1.143E-2 4.693E-2 2 43
25 HP:0002812 Coxa vara 3.164E-4 2.443E-3 1.427E-2
6.107E-2
 2 49
26 HP:0002980 Femoral bowing 3.848E-4 2.854E-3 1.667E-2
7.426E-2
 2 54
27 HP:0002645 Wormian bones 3.992E-4 2.854E-3 1.667E-2
7.705E-2
 2 55
28 HP:0004960 Absent pulmonary artery 6.373E-4 4.242E-3 2.478E-2
1.230E-1
 1 1
29 HP:0005304 Hypoplastic pulmonary veins 6.373E-4 4.242E-3 2.478E-2
1.230E-1
 1 1
30 HP:0000592 Blue sclerae 7.241E-4 4.568E-3 2.669E-2
1.398E-1
 2 74
31 HP:0003170 Abnormality of the acetabulum 7.439E-4 4.568E-3 2.669E-2
1.436E-1
 2 75
32 HP:0002703 Abnormality of skull ossification 7.639E-4 4.568E-3 2.669E-2
1.474E-1
 2 76
33 HP:0003100 Slender long bone 8.047E-4 4.568E-3 2.669E-2
1.553E-1
 2 78
34 HP:0003061 Gracile long bones 8.047E-4 4.568E-3 2.669E-2
1.553E-1
 2 78
35 HP:0000260 Wide anterior fontanel 9.112E-4 5.025E-3 2.936E-2
1.759E-1
 2 83
36 HP:0002992 Abnormality of tibia morphology 9.556E-4 5.123E-3 2.993E-2
1.844E-1
 2 85
37 HP:0000926 Platyspondyly 1.169E-3 6.095E-3 3.561E-2
2.255E-1
 2 94
38 HP:0000236 Abnormality of the anterior fontanelle 1.375E-3 6.899E-3 4.031E-2
2.655E-1
 2 102
39 HP:0008873 Disproportionate short-limb short stature 1.430E-3 6.899E-3 4.031E-2
2.760E-1
 2 104
40 HP:0000325 Triangular face 1.430E-3 6.899E-3 4.031E-2
2.760E-1
 2 104
41 HP:0003367 Abnormality of the femoral neck 1.902E-3 8.783E-3
5.131E-2
3.670E-1
 2 120
42 HP:0006640 Multiple rib fractures 1.911E-3 8.783E-3
5.131E-2
3.689E-1
 1 3
43 HP:0000591 Abnormal sclera morphology 1.965E-3 8.821E-3
5.154E-2
3.793E-1
 2 122
44 HP:0003498 Disproportionate short stature 2.230E-3 9.782E-3
5.715E-2
4.304E-1
 2 130
45 HP:0000932 Abnormality of the posterior cranial fossa 2.369E-3 1.016E-2
5.935E-2
4.571E-1
 2 134
46 HP:0003783 Externally rotated/abducted legs 2.548E-3 1.069E-2
6.245E-2
4.917E-1
 1 4
47 HP:0003366 Abnormality of the femoral neck or head region 2.695E-3 1.107E-2
6.466E-2
5.202E-1
 2 143
48 HP:0002693 Abnormality of the skull base 2.809E-3 1.129E-2
6.598E-2
5.421E-1
 2 146
49 HP:0000239 Large fontanelles 2.886E-3 1.137E-2
6.640E-2
5.569E-1
 2 148
50 HP:0002757 Recurrent fractures 3.042E-3 1.174E-2
6.861E-2
5.872E-1
 2 152
Show 45 more annotations

5: Mouse Phenotype [Display Chart] 6 input genes in category / 568 annotations before applied cutoff / 10355 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 MP:0011204 abnormal visceral yolk sac blood island morphology 1.557E-4 3.396E-2
2.350E-1
8.843E-2
 2 34
2 MP:0004566 myocardial fiber degeneration 1.949E-4 3.396E-2
2.350E-1
1.107E-1
 2 38
3 MP:0020516 abnormal visceral yolk sac mesenchyme morphology 2.161E-4 3.396E-2
2.350E-1
1.228E-1
 2 40
4 MP:0003542 abnormal vascular endothelial cell development 2.618E-4 3.396E-2
2.350E-1
1.487E-1
 2 44
5 MP:0003828 pulmonary edema 2.990E-4 3.396E-2
2.350E-1
1.698E-1
 2 47
6 MP:0011758 renal ischemia 5.794E-4 3.656E-2
2.530E-1
3.291E-1
 1 1
7 MP:0003039 increased time of peak ischemic contracture 5.794E-4 3.656E-2
2.530E-1
3.291E-1
 1 1
8 MP:0000484 abnormal pulmonary artery morphology 6.084E-4 3.656E-2
2.530E-1
3.456E-1
 2 67
9 MP:0008775 abnormal heart ventricle pressure 6.831E-4 3.656E-2
2.530E-1
3.880E-1
 2 71
10 MP:0004090 abnormal sarcomere morphology 9.778E-4 3.656E-2
2.530E-1
5.554E-1
 2 85
11 MP:0010559 heart block 1.144E-3 3.656E-2
2.530E-1
6.500E-1
 2 92
12 MP:0012310 persistent ductus caroticus 1.159E-3 3.656E-2
2.530E-1
6.581E-1
 1 2
13 MP:0020331 increased capillary tortuosity 1.159E-3 3.656E-2
2.530E-1
6.581E-1
 1 2
14 MP:0003337 exocrine pancreas hyperplasia 1.159E-3 3.656E-2
2.530E-1
6.581E-1
 1 2
15 MP:0011313 abnormal kidney efferent arteriole morphology 1.159E-3 3.656E-2
2.530E-1
6.581E-1
 1 2
16 MP:0003182 decreased pulmonary endothelial cell surface 1.159E-3 3.656E-2
2.530E-1
6.581E-1
 1 2
17 MP:0011855 abnormal glomerular filtration barrier morphology 1.159E-3 3.656E-2
2.530E-1
6.581E-1
 1 2
18 MP:0012309 abnormal ductus caroticus morphology 1.159E-3 3.656E-2
2.530E-1
6.581E-1
 1 2
19 MP:0002364 abnormal thymus size 1.330E-3 3.977E-2
2.752E-1
7.556E-1
 3 434
20 MP:0010458 pulmonary trunk hypoplasia 1.737E-3 4.699E-2
3.252E-1
9.869E-1
 1 3
21 MP:0010635 aorta pulmonary collateral arteries 1.737E-3 4.699E-2
3.252E-1
9.869E-1
 1 3
Show 16 more annotations

6: Domain [Display Chart] 6 input genes in category / 72 annotations before applied cutoff / 18735 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 IPR023581 PD growth factor CS InterPro 1.794E-6 3.689E-5 1.793E-4 1.291E-4 2 7
2 IPR000072 PDGF/VEGF dom InterPro 3.074E-6 3.689E-5 1.793E-4 2.213E-4 2 9
3 PS50278 PDGF 2 PROSITE 3.074E-6 3.689E-5 1.793E-4 2.213E-4 2 9
4 PS00249 PDGF 1 PROSITE 3.074E-6 3.689E-5 1.793E-4 2.213E-4 2 9
5 SM00141 PDGF SMART 3.074E-6 3.689E-5 1.793E-4 2.213E-4 2 9
6 PF00341 PDGF Pfam 3.074E-6 3.689E-5 1.793E-4 2.213E-4 2 9
7 2.10.90.10 - Gene3D 1.872E-4 1.647E-3 8.006E-3 1.348E-2 2 67
8 IPR029034 Cystine-knot cytokine InterPro 1.872E-4 1.647E-3 8.006E-3 1.348E-2 2 67
9 IPR033212 Crtap InterPro 3.203E-4 1.647E-3 8.006E-3 2.306E-2 1 1
10 IPR028380 PLC-gamma1 InterPro 3.203E-4 1.647E-3 8.006E-3 2.306E-2 1 1
11 IPR033832 PEDF InterPro 3.203E-4 1.647E-3 8.006E-3 2.306E-2 1 1
12 2.10.160.10 - Gene3D 3.203E-4 1.647E-3 8.006E-3 2.306E-2 1 1
13 PF14554 VEGF C Pfam 3.203E-4 1.647E-3 8.006E-3 2.306E-2 1 1
14 IPR027928 VEGF C InterPro 3.203E-4 1.647E-3 8.006E-3 2.306E-2 1 1
15 IPR016279 PLC-gamma InterPro 6.404E-4 3.074E-3 1.494E-2 4.611E-2 1 2
16 1.20.58.120 - Gene3D 1.281E-3 5.762E-3 2.801E-2
9.220E-2
 1 4
17 SM00264 BAG SMART 1.600E-3 5.762E-3 2.801E-2
1.152E-1
 1 5
18 IPR003103 BAG domain InterPro 1.600E-3 5.762E-3 2.801E-2
1.152E-1
 1 5
19 PS51035 BAG PROSITE 1.600E-3 5.762E-3 2.801E-2
1.152E-1
 1 5
20 PF02179 BAG Pfam 1.600E-3 5.762E-3 2.801E-2
1.152E-1
 1 5
21 SM00149 PLCYc SMART 4.795E-3 1.279E-2
6.215E-2
3.452E-1
 1 15
22 PF09279 EF-hand like Pfam 4.795E-3 1.279E-2
6.215E-2
3.452E-1
 1 15
23 PF00387 PI-PLC-Y Pfam 4.795E-3 1.279E-2
6.215E-2
3.452E-1
 1 15
24 IPR015359 PLC EF-hand-like InterPro 4.795E-3 1.279E-2
6.215E-2
3.452E-1
 1 15
25 PS50008 PIPLC Y DOMAIN PROSITE 4.795E-3 1.279E-2
6.215E-2
3.452E-1
 1 15
26 IPR001192 PI-PLC fam InterPro 4.795E-3 1.279E-2
6.215E-2
3.452E-1
 1 15
27 IPR001711 PLipase C Pinositol-sp Y InterPro 4.795E-3 1.279E-2
6.215E-2
3.452E-1
 1 15
28 SM00148 PLCXc SMART 5.752E-3 1.410E-2
6.853E-2
4.141E-1
 1 18
29 PF00388 PI-PLC-X Pfam 5.752E-3 1.410E-2
6.853E-2
4.141E-1
 1 18
30 PS50007 PIPLC X DOMAIN PROSITE 6.070E-3 1.410E-2
6.853E-2
4.371E-1
 1 19
31 IPR000909 PLipase C PInositol-sp X dom InterPro 6.070E-3 1.410E-2
6.853E-2
4.371E-1
 1 19
32 IPR017946 PLC-like Pdiesterase TIM-brl InterPro 7.981E-3 1.741E-2
8.464E-2
5.746E-1
 1 25
33 3.20.20.190 - Gene3D 7.981E-3 1.741E-2
8.464E-2
5.746E-1
 1 25
34 IPR023795 Serpin CS InterPro 1.021E-2 2.161E-2
1.051E-1
7.348E-1
 1 32
35 IPR023796 Serpin dom InterPro 1.148E-2 2.294E-2
1.115E-1
8.262E-1
 1 36
36 PS00284 SERPIN PROSITE 1.179E-2 2.294E-2
1.115E-1
8.491E-1
 1 37
37 SM00093 SERPIN SMART 1.179E-2 2.294E-2
1.115E-1
8.491E-1
 1 37
38 PF00079 Serpin Pfam 1.211E-2 2.294E-2
1.115E-1
8.719E-1
 1 38
39 IPR000215 Serpin fam InterPro 1.243E-2 2.294E-2
1.115E-1
8.947E-1
 1 39
40 PF00397 WW Pfam 1.496E-2 2.683E-2
1.304E-1
1.000E0
 1 47
41 SM00456 WW SMART 1.528E-2 2.683E-2
1.304E-1
1.000E0
 1 48
42 PS01159 WW DOMAIN 1 PROSITE 1.622E-2 2.707E-2
1.316E-1
1.000E0
 1 51
43 PS50020 WW DOMAIN 2 PROSITE 1.622E-2 2.707E-2
1.316E-1
1.000E0
 1 51
44 IPR001202 WW dom InterPro 1.654E-2 2.707E-2
1.316E-1
1.000E0
 1 52
Show 39 more annotations

7: Pathway [Display Chart] 6 input genes in category / 205 annotations before applied cutoff / 12450 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 PW:0000243 vascular endothelial growth factor signaling Pathway Ontology 1.254E-7 2.319E-5 1.369E-4 2.571E-5 3 24
2 137924 VEGFR1 specific signals BioSystems: Pathway Interaction Database 2.262E-7 2.319E-5 1.369E-4 4.637E-5 3 29
3 137940 Signaling events mediated by VEGFR1 and VEGFR2 BioSystems: Pathway Interaction Database 2.443E-6 1.670E-4 9.855E-4 5.009E-4 3 63
4 1269482 VEGF binds to VEGFR leading to receptor dimerization BioSystems: REACTOME 5.413E-6 2.219E-4 1.310E-3 1.110E-3 2 8
5 1269481 VEGF ligand-receptor interactions BioSystems: REACTOME 5.413E-6 2.219E-4 1.310E-3 1.110E-3 2 8
6 1319988 AGE-RAGE signaling pathway in diabetic complications BioSystems: KEGG 9.587E-6 3.276E-4 1.934E-3 1.965E-3 3 99
7 137937 S1P1 pathway BioSystems: Pathway Interaction Database 3.663E-5 1.073E-3 6.333E-3 7.510E-3 2 20
8 M12975 VEGF, Hypoxia, and Angiogenesis MSigDB C2 BIOCARTA (v6.0) 7.813E-5 2.002E-3 1.182E-2 1.602E-2 2 29
9 868086 Rap1 signaling pathway BioSystems: KEGG 9.114E-5 2.076E-3 1.225E-2 1.868E-2 3 210
10 868085 Ras signaling pathway BioSystems: KEGG 1.149E-4 2.355E-3 1.390E-2 2.355E-2 3 227
11 P00056 VEGF signaling pathway PantherDB 3.161E-4 5.589E-3 3.299E-2
6.481E-2
 2 58
12 83066 VEGF signaling pathway BioSystems: KEGG 3.272E-4 5.589E-3 3.299E-2
6.707E-2
 2 59
13 1269480 Signaling by VEGF BioSystems: REACTOME 3.831E-4 6.041E-3 3.566E-2
7.853E-2
 3 341
14 1404798 EGFR tyrosine kinase inhibitor resistance BioSystems: KEGG 5.866E-4 8.066E-3 4.761E-2
1.203E-1
 2 79
15 83105 Pathways in cancer BioSystems: KEGG 5.902E-4 8.066E-3 4.761E-2
1.210E-1
 3 395
16 695200 HIF-1 signaling pathway BioSystems: KEGG 9.569E-4 1.162E-2
6.859E-2
1.962E-1
 2 101
17 PW:0000353 altered vascular endothelial growth factor signaling involving proteins affecting its expression Pathway Ontology 9.637E-4 1.162E-2
6.859E-2
1.976E-1
 1 2
18 PW:0000351 altered vascular endothelial growth factor signaling involving the main players Pathway Ontology 1.445E-3 1.646E-2
9.715E-2
2.963E-1
 1 3
19 1269367 Platelet degranulation BioSystems: REACTOME 1.627E-3 1.756E-2
1.036E-1
3.336E-1
 2 132
20 1269365 Response to elevated platelet cytosolic Ca2+ BioSystems: REACTOME 1.752E-3 1.795E-2
1.060E-1
3.591E-1
 2 137
21 1269493 PLCG1 events in ERBB2 signaling BioSystems: REACTOME 1.927E-3 1.881E-2
1.110E-1
3.949E-1
 1 4
22 P00005 Angiogenesis PantherDB 2.095E-3 1.953E-2
1.152E-1
4.296E-1
 2 150
23 PW:0000360 the chronic hypoxic response - the hypoxia inducible factor - alpha Pathway Ontology 2.889E-3 2.575E-2
1.520E-1
5.922E-1
 1 6
24 83067 Focal adhesion BioSystems: KEGG 3.655E-3 3.117E-2
1.840E-1
7.493E-1
 2 199
25 782000 Proteoglycans in cancer BioSystems: KEGG 3.801E-3 3.117E-2
1.840E-1
7.792E-1
 2 203
26 1270317 Role of second messengers in netrin-1 signaling BioSystems: REACTOME 4.811E-3 3.398E-2
2.006E-1
9.862E-1
 1 10
27 PW:0000578 scatter factor/hepatocyte growth factor signaling Pathway Ontology 5.291E-3 3.398E-2
2.006E-1
1.000E0
 1 11
28 1268877 Signaling by FGFR4 in disease BioSystems: REACTOME 5.291E-3 3.398E-2
2.006E-1
1.000E0
 1 11
29 1269375 PECAM1 interactions BioSystems: REACTOME 5.770E-3 3.398E-2
2.006E-1
1.000E0
 1 12
30 1270419 Regulation of gene expression by Hypoxia-inducible Factor BioSystems: REACTOME 5.770E-3 3.398E-2
2.006E-1
1.000E0
 1 12
31 M9134 Trka Receptor Signaling Pathway MSigDB C2 BIOCARTA (v6.0) 5.770E-3 3.398E-2
2.006E-1
1.000E0
 1 12
32 1269485 VEGFR2 mediated cell proliferation BioSystems: REACTOME 6.212E-3 3.398E-2
2.006E-1
1.000E0
 2 261
33 1269415 Phospholipase C-mediated cascade; FGFR3 BioSystems: REACTOME 6.250E-3 3.398E-2
2.006E-1
1.000E0
 1 13
34 83051 Cytokine-cytokine receptor interaction BioSystems: KEGG 6.635E-3 3.398E-2
2.006E-1
1.000E0
 2 270
35 138069 S1P4 pathway BioSystems: Pathway Interaction Database 6.729E-3 3.398E-2
2.006E-1
1.000E0
 1 14
36 1269424 Phospholipase C-mediated cascade; FGFR4 BioSystems: REACTOME 7.209E-3 3.398E-2
2.006E-1
1.000E0
 1 15
37 M13324 Hypoxia-Inducible Factor in the Cardiovascular System MSigDB C2 BIOCARTA (v6.0) 7.209E-3 3.398E-2
2.006E-1
1.000E0
 1 15
38 1269350 Platelet activation, signaling and aggregation BioSystems: REACTOME 7.221E-3 3.398E-2
2.006E-1
1.000E0
 2 282
39 1268859 Signaling by EGFRvIII in Cancer BioSystems: REACTOME 7.688E-3 3.398E-2
2.006E-1
1.000E0
 1 16
40 1268860 Constitutive Signaling by EGFRvIII BioSystems: REACTOME 7.688E-3 3.398E-2
2.006E-1
1.000E0
 1 16
41 1269394 Phospholipase C-mediated cascade: FGFR1 BioSystems: REACTOME 7.688E-3 3.398E-2
2.006E-1
1.000E0
 1 16
42 1427841 TFAP2 (AP-2) family regulates transcription of growth factors and their receptors BioSystems: REACTOME 7.688E-3 3.398E-2
2.006E-1
1.000E0
 1 16
43 852705 MicroRNAs in cancer BioSystems: KEGG 8.089E-3 3.398E-2
2.006E-1
1.000E0
 2 299
44 545315 D-myo-inositol-5-phosphate metabolism BioSystems: BIOCYC 8.166E-3 3.398E-2
2.006E-1
1.000E0
 1 17
45 1269405 Phospholipase C-mediated cascade; FGFR2 BioSystems: REACTOME 8.645E-3 3.398E-2
2.006E-1
1.000E0
 1 18
46 M7860 Nerve growth factor pathway (NGF) MSigDB C2 BIOCARTA (v6.0) 8.645E-3 3.398E-2
2.006E-1
1.000E0
 1 18
47 M2349 Pertussis toxin-insensitive CCR5 Signaling in Macrophage MSigDB C2 BIOCARTA (v6.0) 8.645E-3 3.398E-2
2.006E-1
1.000E0
 1 18
48 M16811 Role of Erk5 in Neuronal Survival MSigDB C2 BIOCARTA (v6.0) 8.645E-3 3.398E-2
2.006E-1
1.000E0
 1 18
49 M7552 Role of EGF Receptor Transactivation by GPCRs in Cardiac Hypertrophy MSigDB C2 BIOCARTA (v6.0) 8.645E-3 3.398E-2
2.006E-1
1.000E0
 1 18
50 138002 E-cadherin signaling in keratinocytes BioSystems: Pathway Interaction Database 9.124E-3 3.398E-2
2.006E-1
1.000E0
 1 19
Show 45 more annotations

8: Pubmed [Display Chart] 6 input genes in category / 6715 annotations before applied cutoff / 38193 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 28197761 The pigment epithelium-derived factor (PEDF): an important potential therapeutic agent for infantile hemangioma. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
2 16707486 Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
3 8702615 Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
4 29664206 Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
5 19182495 Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
6 29969324 Evaluation of the growth factors VEGF-a and VEGF-B in the vitreous and serum of patients with macular and retinal vascular diseases. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
7 23346798 PEDF and VEGF plasma level alterations in patients with dry form of age-related degeneration--a possible link to the development of the disease. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
8 19424629 Expression analysis of VEGF-A and VEGF-B: relationship with clinicopathological parameters in bladder cancer. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
9 21236558 The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
10 29596616 VEGF and VEGFB Play Balancing Roles in Adipose Differentiation, Gene Expression, and Function. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
11 25977072 Alterations in plasma vascular endothelial growth factor levels in patients with schizophrenia before and after treatment. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
12 17082651 Expression and functions of the vascular endothelial growth factors and their receptors in human basophils. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
13 29579411 Comparative expression of PEDF and VEGF in human epidermal keratinocytes and dermal fibroblasts: from normal skin to psoriasis. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
14 8602835 Expression of the VEGF-related factor gene in pre- and postnatal mouse. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
15 20688932 Overexpression of VEGF165b in podocytes reduces glomerular permeability. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
16 18704312 Small hairpin loop RNA targeting HIF-1alpha down-regulates VEGF and up-regulates PEDF in human retinal pigment epithelial cells under hypoxic condition. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
17 26450919 Pigment Epithelium-Derived Factor Alleviates Tamoxifen-Induced Endometrial Hyperplasia. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
18 18317782 Cellular distribution of vascular endothelial growth factor A (VEGFA) and B (VEGFB) and VEGF receptors 1 and 2 in focal cortical dysplasia type IIB. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
19 19253105 The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
20 17604022 Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
21 26422603 Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
22 16409998 Contribution of VEGF and PEDF to choroidal angiogenesis: a need for balanced expressions. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
23 12827055 Decreased pigment epithelium-derived factor and increased vascular endothelial growth factor levels in pterygia. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
24 12860293 Regulation of the expression of pigment epithelium-derived factor, an anti-angiogenic factor in human oral squamous cell carcinoma cell lines. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
25 19115638 [Expression of vascular endothelial growth factor and pigment epithelium derived factor in mouse oxygen-induced retinopathy and its significance]. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
26 21275514 Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in macular edema with central retinal vein occlusion. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
27 21636803 Overexpression of VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, leads to insufficient angiogenesis in patients with systemic sclerosis. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
28 22872519 VEGF-A and VEGF-B mRNA expression in gastro-oesophageal cancers. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
29 20228934 Attainment of polarity promotes growth factor secretion by retinal pigment epithelial cells: relevance to age-related macular degeneration. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
30 24145997 A gene signature combining the tissue expression of three angiogenic factors is a prognostic marker in early-stage non-small cell lung cancer. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
31 8637916 Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
32 8607868 Characterization of the murine VEGF-related factor gene. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
33 22547925 PEDF and VEGF-A output from human retinal pigment epithelial cells grown on novel microcarriers. Pubmed 2.057E-8 4.185E-6 3.929E-5 1.381E-4 2 2
34 9689915 A comparative study of the expression patterns for vegf, vegf-b/vrf and vegf-c in the developing and adult mouse. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
35 16839256 Iodide inhibits vascular endothelial growth factor-A expression in cultured human thyroid follicles: a microarray search for effects of thyrotropin and iodide on angiogenesis factors. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
36 11122379 Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
37 19910455 Retinoic acid is a cofactor for translational regulation of vascular endothelial growth factor in human endometrial stromal cells. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
38 16109918 Transgenic overexpression of vascular endothelial growth factor-B isoforms by endothelial cells potentiates postnatal vessel growth in vivo and in vitro. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
39 12912908 Contrasting effects of VEGF gene disruption in embryonic stem cell-derived versus oncogene-induced tumors. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
40 10980614 CAIR-1/BAG-3 forms an EGF-regulated ternary complex with phospholipase C-gamma and Hsp70/Hsc70. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
41 24766673 TFAP2B overexpression contributes to tumor growth and a poor prognosis of human lung adenocarcinoma through modulation of ERK and VEGF/PEDF signaling. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
42 27747237 C3a Increases VEGF and Decreases PEDF mRNA Levels in Human Retinal Pigment Epithelial Cells. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
43 21386905 Cigarette smoke-related hydroquinone dysregulates MCP-1, VEGF and PEDF expression in retinal pigment epithelium in vitro and in vivo. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
44 16189273 Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
45 23444216 Aflibercept. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
46 12670505 Vascular endothelial growth factor upregulates pigment epithelium-derived factor expression via VEGFR-1 in human retinal pigment epithelial cells. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
47 12711260 Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
48 23350126 [Changing of the expression of VEGF genes encoded important regulators of angiogenesis and neurogenesis under hypoxic and ischemic conditions]. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
49 15020256 Osteoblasts and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: possible mediators of angiogenesis and matrix remodeling in the bone. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
50 28627623 P18 peptide, a functional fragment of pigment epithelial-derived factor, inhibits angiogenesis in hepatocellular carcinoma via modulating VEGF/VEGFR2 signalling pathway. Pubmed 6.170E-8 7.533E-6 7.073E-5 4.143E-4 2 3
Show 45 more annotations

9: Interaction [Display Chart] 6 input genes in category / 728 annotations before applied cutoff / 17703 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 int:FLT1 FLT1 interactions 7.064E-8 5.143E-5 3.687E-4 5.143E-5 3 28
2 int:TNXB TNXB interactions 9.569E-7 3.483E-4 2.497E-3 6.966E-4 2 5
3 int:VEGFB VEGFB interactions 1.003E-5 2.434E-3 1.745E-2 7.303E-3 2 15
4 int:LIFR LIFR interactions 2.205E-5 4.013E-3 2.876E-2 1.605E-2 2 22
5 int:SPRY1 SPRY1 interactions 8.193E-5 1.103E-2
7.903E-2
5.964E-2
 2 42
6 int:VEGFA VEGFA interactions 1.072E-4 1.103E-2
7.903E-2
7.807E-2
 2 48
7 int:EPHB2 EPHB2 interactions 1.072E-4 1.103E-2
7.903E-2
7.807E-2
 2 48
8 int:GAB1 GAB1 interactions 1.212E-4 1.103E-2
7.903E-2
8.820E-2
 2 51
9 int:NRP1 NRP1 interactions 1.794E-4 1.451E-2
1.040E-1
1.306E-1
 2 62
10 int:CCDC120 CCDC120 interactions 2.288E-4 1.666E-2
1.194E-1
1.666E-1
 2 70
11 int:KDR KDR interactions 2.842E-4 1.762E-2
1.263E-1
2.069E-1
 2 78
12 int:CRYAB CRYAB interactions 6.385E-4 1.762E-2
1.263E-1
4.648E-1
 2 117
13 int:IGLV3-21 IGLV3-21 interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
14 int:IL36B IL36B interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
15 int:GPR119 GPR119 interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
16 int:LYZL4 LYZL4 interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
17 int:OR8D4 OR8D4 interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
18 int:S100G S100G interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
19 int:SLC35E3 SLC35E3 interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
20 int:OR8H2 OR8H2 interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
21 int:TMIGD2 TMIGD2 interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
22 int:CMTM1 CMTM1 interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
23 int:TMEM270 TMEM270 interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
24 int:OR10G3 OR10G3 interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
25 int:BEAN1 BEAN1 interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
26 int:OR5T1 OR5T1 interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
27 int:C1QTNF7 C1QTNF7 interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
28 int:PIGV PIGV interactions 6.778E-4 1.762E-2
1.263E-1
4.934E-1
 1 2
29 int:MDP1 MDP1 interactions 1.016E-3 1.947E-2
1.396E-1
7.400E-1
 1 3
30 int:ANXA10 ANXA10 interactions 1.016E-3 1.947E-2
1.396E-1
7.400E-1
 1 3
31 int:FAM84A FAM84A interactions 1.016E-3 1.947E-2
1.396E-1
7.400E-1
 1 3
32 int:JRK JRK interactions 1.016E-3 1.947E-2
1.396E-1
7.400E-1
 1 3
33 int:TMEM207 TMEM207 interactions 1.016E-3 1.947E-2
1.396E-1
7.400E-1
 1 3
34 int:EFCAB2 EFCAB2 interactions 1.016E-3 1.947E-2
1.396E-1
7.400E-1
 1 3
35 int:CFAP299 CFAP299 interactions 1.016E-3 1.947E-2
1.396E-1
7.400E-1
 1 3
36 int:OR2T35 OR2T35 interactions 1.016E-3 1.947E-2
1.396E-1
7.400E-1
 1 3
37 int:TMEM252 TMEM252 interactions 1.016E-3 1.947E-2
1.396E-1
7.400E-1
 1 3
38 int:TMEM174 TMEM174 interactions 1.016E-3 1.947E-2
1.396E-1
7.400E-1
 1 3
39 int:PLCG1 PLCG1 interactions 1.310E-3 2.099E-2
1.505E-1
9.534E-1
 2 168
40 int:MIA MIA interactions 1.355E-3 2.099E-2
1.505E-1
9.865E-1
 1 4
41 int:APOPT1 APOPT1 interactions 1.355E-3 2.099E-2
1.505E-1
9.865E-1
 1 4
42 int:CA3 CA3 interactions 1.355E-3 2.099E-2
1.505E-1
9.865E-1
 1 4
43 int:PCDHGB2 PCDHGB2 interactions 1.355E-3 2.099E-2
1.505E-1
9.865E-1
 1 4
44 int:NETO1 NETO1 interactions 1.355E-3 2.099E-2
1.505E-1
9.865E-1
 1 4
45 int:OVOL2 OVOL2 interactions 1.355E-3 2.099E-2
1.505E-1
9.865E-1
 1 4
46 int:DPP10 DPP10 interactions 1.355E-3 2.099E-2
1.505E-1
9.865E-1
 1 4
47 int:DNAJB3 DNAJB3 interactions 1.355E-3 2.099E-2
1.505E-1
9.865E-1
 1 4
48 int:PLA2G6 PLA2G6 interactions 1.694E-3 2.371E-2
1.700E-1
1.000E0
 1 5
49 int:LYVE1 LYVE1 interactions 1.694E-3 2.371E-2
1.700E-1
1.000E0
 1 5
50 int:PGF PGF interactions 1.694E-3 2.371E-2
1.700E-1
1.000E0
 1 5
Show 45 more annotations

10: Cytoband [Display Chart] 6 input genes in category / 6 annotations before applied cutoff / 34661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 10q25.2-q26.2 10q25.2-q26.2 1.731E-4 1.039E-3 2.545E-3 1.039E-3 1 1
2 20q12-q13.1 20q12-q13.1 1.730E-3 5.190E-3 1.271E-2 1.038E-2 1 10
3 6p12 6p12 2.939E-3 5.879E-3 1.440E-2 1.764E-2 1 17
4 3p22.3 3p22.3 5.699E-3 8.549E-3 2.094E-2 3.420E-2 1 33
5 17p13.3 17p13.3 1.599E-2 1.919E-2 4.702E-2
9.595E-2
 1 93
6 11q13 11q13 2.042E-2 2.042E-2
5.004E-2
1.225E-1
 1 119
Show 1 more annotation

11: Transcription Factor Binding Site [Display Chart] 5 input genes in category / 24 annotations before applied cutoff / 9770 genes in category

No results to display

12: Gene Family [Display Chart] 5 input genes in category / 8 annotations before applied cutoff / 18194 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 1267 VEGF family genenames.org 6.040E-7 4.832E-6 1.313E-5 4.832E-6 2 5
2 1139 BCL2 associated athanogene family genenames.org 1.648E-3 6.592E-3 1.792E-2 1.318E-2 1 6
3 832 Phospholipases|C2 domain containing phospholipases genenames.org 5.211E-3 1.390E-2 3.777E-2 4.169E-2 1 19
4 739 Serpin peptidase inhibitors genenames.org 1.013E-2 1.838E-2 4.997E-2
8.102E-2
 1 37
5 467 Phospholipases genenames.org 1.149E-2 1.838E-2 4.997E-2
9.192E-2
 1 42
6 741 SH2 domain containing genenames.org 2.745E-2 3.660E-2
9.948E-2
2.196E-1
 1 101
Show 1 more annotation

13: Coexpression [Display Chart] 6 input genes in category / 1080 annotations before applied cutoff / 23137 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 M3955 Integrin, VEGF, Wnt and TGFbeta signaling pathway genes up-regulated in PC-3 cells (prostate cancer) after knockdown of PDEF [GeneID=25803] by RNAi. MSigDB C2: CGP Curated Gene Sets (v6.0) 5.502E-7 5.942E-4 4.493E-3 5.942E-4 3 71
2 M3495 Angiogenic and metastatic genes changed in RKO cells (colorectal cancer) upon perturbation of key components of AKT pathway. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.520E-6 1.361E-3 1.029E-2 2.721E-3 2 10
3 M2225 Genes down-regulated in osteoblasts from wild type male mice compared to those with AR [GeneID=367] knockout. MSigDB C2: CGP Curated Gene Sets (v6.0) 9.565E-6 3.371E-3 2.549E-2 1.033E-2 2 19
4 M6634 Genes down-regulated in bone marrow-derived macrophages with IL10 [GeneID=3486] and 180 min stimulation of: LPS versus IL10 [GeneID=3486] and LPS. MSigDB C7: Immunologic Signatures (v6.0) 1.248E-5 3.371E-3 2.549E-2 1.348E-2 3 200
5 19458276-Table3 Mouse Stemcell Bol09 31genes GeneSigDB 2.430E-5 3.981E-3 3.010E-2 2.624E-2 2 30
6 M19682 Genes down-regulated in huT78R cells (cutaneous T-cell lymphoma, CTCL) resistant to IFNA2 [GeneID=3440] compared to the IFN2A sensitive parental cell line. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.770E-5 3.981E-3 3.010E-2 2.992E-2 2 32
7 17295094-GeneList Human Breast VandenEynden07 269genes-hypoxia angiogenesis GeneSigDB 2.832E-5 3.981E-3 3.010E-2 3.058E-2 3 263
8 M1612 Strongly up-regulated at 2 h during differentiation of 3T3-L1 cells (fibroblast) into adipocytes. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.949E-5 3.981E-3 3.010E-2 3.184E-2 2 33
9 M1675 Selected genes up-regulated during differentiation of 3T3-L1 cells (fibroblast) into adipocytes in response to adipogenic hormones. MSigDB C2: CGP Curated Gene Sets (v6.0) 6.555E-5 7.254E-3
5.486E-2
7.080E-2
 2 49
10 M1597 Cluster 2: genes maximally expressed at 2 h time point during differentiation of 3T3-L1 fibroblasts into adipocytes (cluster 2) in response to adipogenic hormones. MSigDB C2: CGP Curated Gene Sets (v6.0) 7.105E-5 7.254E-3
5.486E-2
7.674E-2
 2 51
11 16585153-Table1 Mouse Skin Hagendoorn06 54genes GeneSigDB 7.389E-5 7.254E-3
5.486E-2
7.980E-2
 2 52
12 15696083-Table1 Human Lung Wang05 64genes GeneSigDB 8.888E-5 7.999E-3
6.049E-2
9.599E-2
 2 57
13 16618722-Table1 Human InVitro Glesne06 108genes GeneSigDB 2.688E-4 2.233E-2
1.689E-1
2.903E-1
 2 99
14 21205295-TableS2 Mouse Viral Buonomo11 116genes GeneSigDB 3.024E-4 2.264E-2
1.712E-1
3.266E-1
 2 105
15 M5922 Genes up-regulated during unfolded protein response, a cellular stress response related to the endoplasmic reticulum. MSigDB H: Hallmark Gene Sets (v6.0) 3.501E-4 2.264E-2
1.712E-1
3.781E-1
 2 113
16 16357179-Table2 Human Lymphoma Lecane05 131genes GeneSigDB 4.214E-4 2.264E-2
1.712E-1
4.551E-1
 2 124
17 17304354-Table2s Human Lymphoma Piccaluga07 185genes GeneSigDB 4.630E-4 2.264E-2
1.712E-1
5.001E-1
 2 130
18 M5825 Angiogenic markers down-regulated in lymph endothelial cells upon infection with KSHV (Kaposi's sarcoma herpes virus). MSigDB C2: CGP Curated Gene Sets (v6.0) 5.215E-4 2.264E-2
1.712E-1
5.633E-1
 2 138
19 M2802 Genes up-regulated in primary keratinocytes from RB1 and RBL1 [Gene ID=5925, 5933] skin specific knockout mice. MSigDB C6: Oncogenic Signatures (v6.0) 5.291E-4 2.264E-2
1.712E-1
5.714E-1
 2 139
20 M2696 Genes up-regulated in HEK293 cells (kidney fibroblasts) upon knockdown of RELA [Gene ID=5970] gene by RNAi. MSigDB C6: Oncogenic Signatures (v6.0) 6.075E-4 2.264E-2
1.712E-1
6.561E-1
 2 149
21 M1484 Genes up-regulated in pancreatic cells from mice with double knockout of E2F1 [GeneID=1869] and E2F2 [GeneID=1870] compared to wild type. MSigDB C2: CGP Curated Gene Sets (v6.0) 6.239E-4 2.264E-2
1.712E-1
6.738E-1
 2 151
22 M9104 Genes down-regulated in CD4 T conv: control versus over-expression of IKZF4 and FOXP3 [GeneID=64375;50943]. MSigDB C7: Immunologic Signatures (v6.0) 6.488E-4 2.264E-2
1.712E-1
7.007E-1
 2 154
23 17183660-TableS1a Mouse Breast Bacac06 256genes StromaUp GeneSigDB 7.000E-4 2.264E-2
1.712E-1
7.560E-1
 2 160
24 M15047 The 'NPM1 signature 3': genes down-regulated in pediatric AML (acute myeloid leukemia) with mutated NPM1 [GeneID=4869] compared to the AML cases with intact NPM1 and MLL [GeneID=4297]. MSigDB C2: CGP Curated Gene Sets (v6.0) 7.175E-4 2.264E-2
1.712E-1
7.749E-1
 2 162
25 M12112 Angiogenic markers up-regulated in lymph endothelial cells upon infection with KSHV (Kaposi's sarcoma herpes virus). MSigDB C2: CGP Curated Gene Sets (v6.0) 7.441E-4 2.264E-2
1.712E-1
8.037E-1
 2 165
26 M6697 Genes up-regulated in endothelial cells: interferon alpha versus IFNG [GeneID=3458]. MSigDB C7: Immunologic Signatures (v6.0) 7.531E-4 2.264E-2
1.712E-1
8.134E-1
 2 166
27 M5649 Genes down-regulated in comparison of peripheral blood mononuclear cells (PBMC) from healthy donors versus PBMC from patients with acute S. pneumoniae infection. MSigDB C7: Immunologic Signatures (v6.0) 7.804E-4 2.264E-2
1.712E-1
8.428E-1
 2 169
28 M6738 Genes up-regulated in T cells: CD4 [GeneID=920] versus CD8. MSigDB C7: Immunologic Signatures (v6.0) 8.943E-4 2.264E-2
1.712E-1
9.658E-1
 2 181
29 M12621 Genes up-regulated in Wilm's tumor samples compared to fetal kidney. MSigDB C2: CGP Curated Gene Sets (v6.0) 9.041E-4 2.264E-2
1.712E-1
9.764E-1
 2 182
30 M19867 Genes down-regulated in acute myeloid leukemia (AML) with respect to cellular localization of NPM1 [GeneID=4869]: cytoplasmic vs. nucleolar. MSigDB C2: CGP Curated Gene Sets (v6.0) 9.239E-4 2.264E-2
1.712E-1
9.978E-1
 2 184
31 M3113 Genes up-regulated in comparison of effector memory T cells versus peripheral blood mononuclear cells (PBMC). MSigDB C7: Immunologic Signatures (v6.0) 1.079E-3 2.264E-2
1.712E-1
1.000E0
 2 199
32 M3359 Genes up-regulated in comparison of Th2 cells versus Th1 cells. MSigDB C7: Immunologic Signatures (v6.0) 1.079E-3 2.264E-2
1.712E-1
1.000E0
 2 199
33 M4946 Genes down-regulated in comparison of monocytes versus plasmacytoid dendritic cells (pDC). MSigDB C7: Immunologic Signatures (v6.0) 1.079E-3 2.264E-2
1.712E-1
1.000E0
 2 199
34 M5191 Genes down-regulated in comparison of dendritic cells (DC) exposed to M. tuberculosis versus macrophages exposed to L. major. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
35 M3078 Genes up-regulated in comparison of healthy CD4 [GeneID=920] T cells versus healthy myeloid cells. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
36 M6583 Genes down-regulated in monocytes: untreated versus CSF1 [GeneID=1435] knockout at day 3. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
37 M9186 Genes up-regulated in CD4 T conv over-expressing FOXP3 [GeneID=50943] versus GATA1 and FOXP3 [GeneID=2623;50943]. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
38 M3116 Genes up-regulated in comparison of central memory T cells versus peripheral blood mononuclear cells (PBMC). MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
39 M3613 Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 72 h after stimulation with antigen-B7-1. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
40 M4693 Genes up-regulated in comparison of unstimulated dendritic cells (DC) at 0 h versus DCs stimulated with R848 for 8 h. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
41 M9748 Genes up-regulated in Ly6c int CXCR5+ CD4 [GeneID=643;920] T cells: effector during acute infection of LCMV versus memory. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
42 M6247 Genes down-regulated in immature CD4 [GeneID=920] single positive cells versus double positive thymocytes. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
43 M3610 Genes down-regulated in comparison of CD8 T cells at 0 h versus those at 72 h after stimulation with IL12. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
44 M6587 Genes down-regulated in monocytes versus classically activated (M1) macrophages. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
45 M5381 Genes up-regulated in comparison of memory CD4 [GeneID=920] T cells versus Th2 cells. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
46 M6538 Genes down-regulated in epithelial cells (6h): interferon alpha versus interferon alpha and IFNG [GeneID=3458]. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
47 M3084 Genes up-regulated in comparison of systemic lupus erythematosus CD4 [GeneID=920] T cells versus systemic lupus erythematosus B cells. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
48 M4143 Genes up-regulated in comparison of dendritic cells (DC) stimulated with Gardiquimod (TLR7 agonist) at 0.5 h versus those stimulated with Gardiquimod (TLR7 agonist) at 24 h. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
49 M8959 Genes up-regulated in lymph node from aged PPARG [GeneID=5468] knockout mice: T reg versus T conv. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
50 M3121 Genes down-regulated in comparison of peripheral mononuclear blood cells (PBMC) versus memory T cells. MSigDB C7: Immunologic Signatures (v6.0) 1.090E-3 2.264E-2
1.712E-1
1.000E0
 2 200
Show 45 more annotations

14: Coexpression Atlas [Display Chart] 6 input genes in category / 630 annotations before applied cutoff / 21829 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Trachea Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Trachea Tabula Muris Consortium 1.355E-5 8.539E-3
5.998E-2
 8.539E-3 3 194
2 10X Human 8K PBMC Myeloid Subtype Myeloid-S100A9 CST3 S100A8 Top 200 Genes 10X Human 8K PBMC Myeloid Subtype Myeloid-S100A9 CST3 S100A8 Top 200 Genes 1.055E-4 3.322E-2
2.333E-1
6.644E-2
 3 386
3 GSM777050 500 Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 Immgen.org, GSE15907 1.854E-4 3.894E-2
2.735E-1
1.168E-1
 3 467
4 Sample Type by Project: Shred 1/TCGA-Prostate/Prostate Adenocarcinoma/Ductal Adenocarcinoma/3/4 Sample Type by Project: Shred 1/TCGA-Prostate/Prostate Adenocarcinoma/Ductal Adenocarcinoma/3/4 TCGA-Prostate 6.910E-4 4.310E-2
3.027E-1
4.353E-1
 2 150
5 Human Kidney Development/Human Kidney Fetal Kidney Cell Atlas: (Tang et al 2018)/Human/Cell Subclass of Age of Cell Class of Tissue (subtype)/Mesangium (MG)/late fetal/MG a Human Kidney Development/Human Kidney Fetal Kidney Cell Atlas: (Tang et al 2018)/Human/Cell Subclass of Age of Cell Class of Tissue (subtype)/Mesangium (MG)/late fetal/MG a Fetal, Development 8.244E-4 4.310E-2
3.027E-1
5.194E-1
 1 3
6 gudmap dev gonad e13.5 F VascAssocMesenchStromOvary MafB k1 1000 dev gonad e13.5 F VascAssocMesenchStromOvary MafB k-means-cluster#1 top-relative-expression-ranked 1000 Gudmap Mouse ST 1.0 8.451E-4 4.310E-2
3.027E-1
5.324E-1
 2 166
7 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Ureter others/Kidney Normal Wilms Ureter others Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney Ureter others/Kidney Normal Wilms Ureter others Adult, Development, and Cancer types 9.924E-4 4.310E-2
3.027E-1
6.252E-1
 2 180
8 Sample Type by Project: Shred 1/TCGA-Lung/Lung Carcinoma/Lung Acinar Adenocarcinoma/4/4 Sample Type by Project: Shred 1/TCGA-Lung/Lung Carcinoma/Lung Acinar Adenocarcinoma/4/4 TCGA-Lung 1.014E-3 4.310E-2
3.027E-1
6.391E-1
 2 182
9 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Diaphrag Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Diaphrag Tabula Muris Consortium 1.093E-3 4.310E-2
3.027E-1
6.888E-1
 2 189
10 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Limb Muscle/mesenchymal stem cell Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Limb Muscle/mesenchymal stem cell Tabula Muris Consortium 1.105E-3 4.310E-2
3.027E-1
6.960E-1
 2 190
11 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Fat/mesenchymal stem cell of adipose Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Fat/mesenchymal stem cell of adipose Tabula Muris Consortium 1.105E-3 4.310E-2
3.027E-1
6.960E-1
 2 190
12 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Diaphrag/mesenchymal stem cell Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Diaphrag/mesenchymal stem cell Tabula Muris Consortium 1.116E-3 4.310E-2
3.027E-1
7.033E-1
 2 191
13 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney EN-A/Kidney Tumour PapRCC EN-A/Kidney Tumour PapRCC EN8 Human Kidney Cell Atlas/Human/Adult, Development, and Cancer types/Cell Type of Cell Class of Tissue/Kidney EN-A/Kidney Tumour PapRCC EN-A/Kidney Tumour PapRCC EN8 Adult, Development, and Cancer types 1.116E-3 4.310E-2
3.027E-1
7.033E-1
 2 191
14 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Pancreas/pancreatic stellate cell Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Pancreas/pancreatic stellate cell Tabula Muris Consortium 1.128E-3 4.310E-2
3.027E-1
7.106E-1
 2 192
15 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Bladder/bladder cell Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Bladder/bladder cell Tabula Muris Consortium 1.128E-3 4.310E-2
3.027E-1
7.106E-1
 2 192
16 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Aorta/fibroblast Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Aorta/fibroblast Tabula Muris Consortium 1.140E-3 4.310E-2
3.027E-1
7.179E-1
 2 193
17 Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Trachea/mesenchymal cell Tabula Muris Consortium/Tabula Muris Consortium/Tissues and cell class/Trachea/mesenchymal cell Tabula Muris Consortium 1.163E-3 4.310E-2
3.027E-1
7.328E-1
 2 195
18 Lungmap Mouse Lung PND1 Epithelial Subtype AT1-C Lungmap Mouse Lung PND1 Epithelial Subtype AT1-C Lungmap CCHMC 1.517E-3 4.796E-2
3.368E-1
9.556E-1
 2 223
19 gudmap dev gonad e11.5 F GonadVasMes Flk k1 1000 dev gonad e11.5 F GonadVasMes Flk k-means-cluster#1 top-relative-expression-ranked 1000 Gudmap Mouse ST 1.0 1.530E-3 4.796E-2
3.368E-1
9.641E-1
 2 224
20 Lungmap Mouse Lung PND1 Epithelial Subtype AT1-A Lungmap Mouse Lung PND1 Epithelial Subtype AT1-A Lungmap CCHMC 1.599E-3 4.796E-2
3.368E-1
1.000E0
 2 229
21 Facebase RNAseq ratio e10.5 MaxillaryArch vs Mandibular 2500 K1 FacebaseRNAseq ratio e10.5 MaxillaryArch vs Mandibular top-relative-expression-ranked 2500 k-means-cluster#1 FaceBase_RNAseq 1.599E-3 4.796E-2
3.368E-1
1.000E0
 2 229
Show 16 more annotations

15: Computational [Display Chart] 4 input genes in category / 34 annotations before applied cutoff / 10037 genes in category

No results to display

16: MicroRNA [Display Chart] 6 input genes in category / 310 annotations before applied cutoff / 72241 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 hsa-miR-429:Functional MTI Functional MTI miRTarbase 6.475E-5 7.338E-3 4.634E-2 2.007E-2 2 151
2 hsa-miR-361-5p:Functional MTI Functional MTI miRTarbase 7.270E-5 7.338E-3 4.634E-2 2.254E-2 2 160
3 hsa-miR-369-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 7.545E-5 7.338E-3 4.634E-2 2.339E-2 2 163
4 hsa-miR-200b-3p:Functional MTI Functional MTI miRTarbase 9.823E-5 7.338E-3 4.634E-2 3.045E-2 2 186
5 hsa-miR-200c-3p:Functional MTI Functional MTI miRTarbase 1.300E-4 7.338E-3 4.634E-2 4.030E-2 2 214
6 hsa-miR-1236:PITA hsa-miR-1236:PITA TOP PITA 1.634E-4 7.338E-3 4.634E-2
5.066E-2
 2 240
7 hsa-miR-205:PITA hsa-miR-205:PITA TOP PITA 2.222E-4 7.338E-3 4.634E-2
6.890E-2
 2 280
8 hsa-miR-4763-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.270E-4 7.338E-3 4.634E-2
7.037E-2
 2 283
9 hsa-miR-1207-5p:Functional MTI Functional MTI miRTarbase 2.351E-4 7.338E-3 4.634E-2
7.287E-2
 2 288
10 hsa-miR-5692a:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.367E-4 7.338E-3 4.634E-2
7.338E-2
 2 289
11 hsa-miR-1208:PITA hsa-miR-1208:PITA TOP PITA 2.618E-4 7.379E-3 4.660E-2
8.116E-2
 2 304
12 hsa-miR-1:PITA hsa-miR-1:PITA TOP PITA 3.892E-4 8.664E-3
5.472E-2
1.207E-1
 2 371
13 hsa-miR-206:PITA hsa-miR-206:PITA TOP PITA 3.892E-4 8.664E-3
5.472E-2
1.207E-1
 2 371
14 hsa-miR-613:PITA hsa-miR-613:PITA TOP PITA 3.913E-4 8.664E-3
5.472E-2
1.213E-1
 2 372
15 hsa-miR-452:PITA hsa-miR-452:PITA TOP PITA 5.737E-4 1.161E-2
7.333E-2
1.779E-1
 2 451
16 hsa-miR-369-3p:TargetScan hsa-miR-369-3p TargetScan 5.993E-4 1.161E-2
7.333E-2
1.858E-1
 2 461
17 hsa-miR-598-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 9.133E-4 1.665E-2
1.052E-1
2.831E-1
 1 11
18 hsa-miR-718:Functional MTI Functional MTI miRTarbase 1.245E-3 2.145E-2
1.354E-1
3.860E-1
 1 15
19 hsa-miR-1180:PITA hsa-miR-1180:PITA TOP PITA 1.660E-3 2.708E-2
1.710E-1
5.146E-1
 1 20
20 hsa-miR-423-3p:PITA hsa-miR-423-3p:PITA TOP PITA 1.992E-3 2.728E-2
1.723E-1
6.174E-1
 1 24
21 hsa-miR-4497:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.483E-3 2.728E-2
1.723E-1
1.000E0
 1 42
22 hsa-miR-6793-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.063E-3 2.728E-2
1.723E-1
1.000E0
 1 49
23 hsa-miR-1298-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.477E-3 2.728E-2
1.723E-1
1.000E0
 1 54
24 hsa-miR-1-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.477E-3 2.728E-2
1.723E-1
1.000E0
 1 54
25 hsa-miR-6759-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.642E-3 2.728E-2
1.723E-1
1.000E0
 1 56
26 hsa-miR-126-3p:Functional MTI Functional MTI miRTarbase 4.725E-3 2.728E-2
1.723E-1
1.000E0
 1 57
27 hsa-miR-6807-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 4.973E-3 2.728E-2
1.723E-1
1.000E0
 1 60
28 hsa-miR-5682:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.304E-3 2.728E-2
1.723E-1
1.000E0
 1 64
29 hsa-miR-6757-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.387E-3 2.728E-2
1.723E-1
1.000E0
 1 65
30 hsa-miR-4318:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.387E-3 2.728E-2
1.723E-1
1.000E0
 1 65
31 hsa-miR-5187-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.469E-3 2.728E-2
1.723E-1
1.000E0
 1 66
32 hsa-miR-4699-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.552E-3 2.728E-2
1.723E-1
1.000E0
 1 67
33 hsa-miR-134-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.552E-3 2.728E-2
1.723E-1
1.000E0
 1 67
34 hsa-miR-155-3p:Functional MTI Functional MTI miRTarbase 5.635E-3 2.728E-2
1.723E-1
1.000E0
 1 68
35 hsa-miR-101-5p:Functional MTI Functional MTI miRTarbase 5.635E-3 2.728E-2
1.723E-1
1.000E0
 1 68
36 hsa-miR-6862-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.635E-3 2.728E-2
1.723E-1
1.000E0
 1 68
37 hsa-miR-942-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.717E-3 2.728E-2
1.723E-1
1.000E0
 1 69
38 hsa-miR-4253:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.717E-3 2.728E-2
1.723E-1
1.000E0
 1 69
39 hsa-miR-299-3p:Functional MTI Functional MTI miRTarbase 5.883E-3 2.728E-2
1.723E-1
1.000E0
 1 71
40 hsa-miR-6870-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.131E-3 2.728E-2
1.723E-1
1.000E0
 1 74
41 hsa-miR-296-5p:Functional MTI Functional MTI miRTarbase 6.131E-3 2.728E-2
1.723E-1
1.000E0
 1 74
42 hsa-miR-568:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.131E-3 2.728E-2
1.723E-1
1.000E0
 1 74
43 hsa-miR-374a-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.213E-3 2.728E-2
1.723E-1
1.000E0
 1 75
44 hsa-miR-6815-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.296E-3 2.728E-2
1.723E-1
1.000E0
 1 76
45 hsa-miR-4648:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.296E-3 2.728E-2
1.723E-1
1.000E0
 1 76
46 hsa-miR-4662a-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.378E-3 2.728E-2
1.723E-1
1.000E0
 1 77
47 hsa-miR-6865-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.378E-3 2.728E-2
1.723E-1
1.000E0
 1 77
48 hsa-miR-551b:mirSVR highEffct hsa-miR-551b:mirSVR conserved highEffect-0.5 MicroRNA.org 6.461E-3 2.728E-2
1.723E-1
1.000E0
 1 78
49 hsa-miR-4654:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 6.461E-3 2.728E-2
1.723E-1
1.000E0
 1 78
50 hsa-miR-4448:Functional MTI Functional MTI miRTarbase 6.461E-3 2.728E-2
1.723E-1
1.000E0
 1 78
Show 45 more annotations

17: Drug [Display Chart] 6 input genes in category / 3628 annotations before applied cutoff / 22841 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 CID000000501 AC1Q5S71 Stitch 4.392E-8 1.593E-4 1.398E-3 1.593E-4 4 170
2 ctd:C005311 nornicotine CTD 3.450E-7 6.257E-4 5.490E-3 1.251E-3 2 4
3 CID005362420 verteporfin Stitch 6.029E-6 4.371E-3 3.835E-2 2.187E-2 2 15
4 CID000151803 N-octanoyl-beta-D-glucosylamine Stitch 7.807E-6 4.371E-3 3.835E-2 2.832E-2 2 17
5 5584 UP trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT HG-U133A Broad Institute CMAP Up 9.460E-6 4.371E-3 3.835E-2 3.432E-2 3 180
6 ctd:D000069997 Mastic Resin CTD 9.814E-6 4.371E-3 3.835E-2 3.561E-2 2 19
7 2648 DN Hesperidin [520-26-3]; Down 200; 6.6uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.221E-5 4.371E-3 3.835E-2 4.430E-2 3 196
8 7472 UP Chlorphensin carbamate [886-74-8]; Up 200; 16.2uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.240E-5 4.371E-3 3.835E-2 4.498E-2 3 197
9 2834 UP Pentamidine isethionate [140-64-7]; Up 200; 6.8uM; MCF7; HT HG-U133A Broad Institute CMAP Up 1.278E-5 4.371E-3 3.835E-2 4.636E-2 3 199
10 2803 DN Yohimbinic acid monohydrate [27801-27-2]; Down 200; 11.2uM; MCF7; HT HG-U133A Broad Institute CMAP Down 1.278E-5 4.371E-3 3.835E-2 4.636E-2 3 199
11 ctd:D013412 Sulfadimethoxine CTD 1.325E-5 4.371E-3 3.835E-2 4.808E-2 2 22
12 ctd:C432747 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC CTD 1.721E-5 5.201E-3 4.563E-2
6.242E-2
 2 25
13 CID000092326 stacker Stitch 1.864E-5 5.201E-3 4.563E-2
6.762E-2
 2 26
14 CID011840982 N5-sulfono Flavin-adenine Dinucleotide Stitch 2.665E-5 6.906E-3
6.059E-2
9.669E-2
 2 31
15 CID000020483 bis(2-hydroxyethyl) trisulfide Stitch 4.026E-5 9.001E-3
7.897E-2
1.461E-1
 2 38
16 CID000015542 N,N-diethylbenzamide Stitch 4.026E-5 9.001E-3
7.897E-2
1.461E-1
 2 38
17 CID000079084 1-isocyanopropane Stitch 4.243E-5 9.001E-3
7.897E-2
1.539E-1
 2 39
18 CID000106696 Lc 6 Stitch 4.466E-5 9.001E-3
7.897E-2
1.620E-1
 2 40
19 ctd:D015766 Albendazole CTD 5.921E-5 1.131E-2
9.920E-2
2.148E-1
 2 46
20 CID000461545 AGEPC Stitch 7.252E-5 1.184E-2
1.039E-1
2.631E-1
 3 356
21 CID000005533 trazodone Stitch 7.290E-5 1.184E-2
1.039E-1
2.645E-1
 2 51
22 CID000100154 combretastatin Stitch 7.290E-5 1.184E-2
1.039E-1
2.645E-1
 2 51
23 ctd:D000068677 Sildenafil Citrate CTD 7.877E-5 1.184E-2
1.039E-1
2.858E-1
 2 53
24 CID000003460 geldanamicin Stitch 8.330E-5 1.184E-2
1.039E-1
3.022E-1
 3 373
25 ctd:C540355 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one CTD 8.330E-5 1.184E-2
1.039E-1
3.022E-1
 3 373
26 ctd:C013649 plastochromanol 8 CTD 8.487E-5 1.184E-2
1.039E-1
3.079E-1
 2 55
27 CID000448249 O-Ir Stitch 9.119E-5 1.225E-2
1.075E-1
3.308E-1
 2 57
28 CID000111332 anecortave acetate Stitch 9.774E-5 1.266E-2
1.111E-1
3.546E-1
 2 59
29 CID000133111 Zeocin Stitch 1.045E-4 1.307E-2
1.147E-1
3.792E-1
 2 61
30 CID006456015 sunitinib malate Stitch 1.151E-4 1.392E-2
1.221E-1
4.176E-1
 2 64
31 ctd:C064769 N-acetylsphingosine CTD 1.224E-4 1.433E-2
1.257E-1
4.442E-1
 2 66
32 CID004369535 P-O-O Stitch 1.339E-4 1.475E-2
1.294E-1
4.856E-1
 2 69
33 CID000007994 PA-e Stitch 1.418E-4 1.475E-2
1.294E-1
5.143E-1
 2 71
34 ctd:D009020 Morphine CTD 1.434E-4 1.475E-2
1.294E-1
5.204E-1
 3 448
35 CID000006436 triamcinolone acetonide Stitch 1.499E-4 1.475E-2
1.294E-1
5.438E-1
 2 73
36 ctd:D000537 Aluminum Oxide CTD 1.625E-4 1.475E-2
1.294E-1
5.895E-1
 2 76
37 ctd:C064116 S-(1,1,2,2-tetrafluoroethyl)cysteine CTD 1.712E-4 1.475E-2
1.294E-1
6.210E-1
 2 78
38 CID000123977 YIGSR Stitch 1.756E-4 1.475E-2
1.294E-1
6.370E-1
 2 79
39 ctd:D008555 Melitten CTD 1.938E-4 1.475E-2
1.294E-1
7.033E-1
 2 83
40 CID006323299 1m0q Stitch 2.081E-4 1.475E-2
1.294E-1
7.551E-1
 2 86
41 CID000008839 ricinelaidic acid Stitch 2.540E-4 1.475E-2
1.294E-1
9.215E-1
 2 95
42 CID000002046 AG126 Stitch 2.594E-4 1.475E-2
1.294E-1
9.410E-1
 2 96
43 CID000069175 2,4-dimethoxybenzaldehyde Stitch 2.627E-4 1.475E-2
1.294E-1
9.530E-1
 1 1
44 CID009547961 3-O-D Stitch 2.627E-4 1.475E-2
1.294E-1
9.530E-1
 1 1
45 ctd:C060203 1-stearoyl-2-arachidonoylphosphatidic acid CTD 2.627E-4 1.475E-2
1.294E-1
9.530E-1
 1 1
46 ctd:C031599 dipalmitoylphosphatidic acid CTD 2.627E-4 1.475E-2
1.294E-1
9.530E-1
 1 1
47 ctd:C045229 N-(deoxyguanosin-8-yl)-1-aminopyrene CTD 2.627E-4 1.475E-2
1.294E-1
9.530E-1
 1 1
48 ctd:C000604795 4-hydroxy-7-oxo-5-heptenoic acid lactone CTD 2.627E-4 1.475E-2
1.294E-1
9.530E-1
 1 1
49 DB01270 Ranibizumab Drug Bank 2.627E-4 1.475E-2
1.294E-1
9.530E-1
 1 1
50 ctd:C025602 dimyristoylphosphatidic acid CTD 2.627E-4 1.475E-2
1.294E-1
9.530E-1
 1 1
Show 45 more annotations

18: Disease [Display Chart] 6 input genes in category / 1014 annotations before applied cutoff / 16205 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 C4068858 Avascular retina DisGeNET BeFree 2.397E-6 1.144E-3 8.579E-3 2.431E-3 2 7
2 C0409495 Protrusio acetabuli DisGeNET Curated 2.397E-6 1.144E-3 8.579E-3 2.431E-3 2 7
3 C4024896 Motor neuron atrophy DisGeNET BeFree 3.385E-6 1.144E-3 8.579E-3 3.432E-3 3 91
4 C0162291 Retinal ischemia DisGeNET BeFree 6.274E-6 1.272E-3 9.541E-3 6.362E-3 2 11
5 C0268362 Osteogenesis imperfecta type III (disorder) DisGeNET Curated 6.274E-6 1.272E-3 9.541E-3 6.362E-3 2 11
6 C0268363 Osteogenesis imperfecta type IV (disorder) DisGeNET Curated 7.528E-6 1.272E-3 9.541E-3 7.633E-3 2 12
7 C0262431 Compression fracture of vertebral column DisGeNET Curated 1.038E-5 1.308E-3 9.806E-3 1.052E-2 2 14
8 C0410550 Collapse of vertebra DisGeNET Curated 1.038E-5 1.308E-3 9.806E-3 1.052E-2 2 14
9 C3714948 PACHYONYCHIA CONGENITA 3 DisGeNET Curated 1.161E-5 1.308E-3 9.806E-3 1.177E-2 3 137
10 C0239138 Hip joint varus deformity - observation DisGeNET Curated 3.142E-5 3.148E-3 2.360E-2 3.186E-2 2 24
11 C0033581 prostatitis DisGeNET Curated 3.414E-5 3.148E-3 2.360E-2 3.462E-2 2 25
12 C0005944 Metabolic Bone Disorder DisGeNET Curated 4.300E-5 3.634E-3 2.725E-2 4.360E-2 2 28
13 C0085083 Ovarian Hyperstimulation Syndrome DisGeNET Curated 5.287E-5 4.124E-3 3.093E-2
5.361E-2
 2 31
14 C0018799 Heart Diseases DisGeNET Curated 1.158E-4 5.776E-3 4.332E-2
1.175E-1
 3 296
15 C0220656 Malignant ascites DisGeNET BeFree 1.333E-4 5.776E-3 4.332E-2
1.352E-1
 2 49
16 C0029434 Osteogenesis Imperfecta DisGeNET Curated 1.333E-4 5.776E-3 4.332E-2
1.352E-1
 2 49
17 C0346990 Carcinomatosis of peritoneal cavity DisGeNET BeFree 1.333E-4 5.776E-3 4.332E-2
1.352E-1
 2 49
18 C0017075 Ganglioneuroma DisGeNET Curated 1.503E-4 5.776E-3 4.332E-2
1.524E-1
 2 52
19 C1519666 Tumor-Associated Vasculature DisGeNET BeFree 1.503E-4 5.776E-3 4.332E-2
1.524E-1
 2 52
20 C0011875 Diabetic Angiopathies DisGeNET Curated 1.561E-4 5.776E-3 4.332E-2
1.583E-1
 2 53
21 C0035309 Retinal Diseases DisGeNET Curated 1.599E-4 5.776E-3 4.332E-2
1.622E-1
 3 330
22 C0035344 Retinopathy of Prematurity DisGeNET Curated 1.744E-4 5.776E-3 4.332E-2
1.768E-1
 2 56
23 C1997217 Low grade glioma DisGeNET BeFree 1.871E-4 5.776E-3 4.332E-2
1.897E-1
 2 58
24 C0677944 Sentinel node (disorder) DisGeNET BeFree 1.871E-4 5.776E-3 4.332E-2
1.897E-1
 2 58
25 C0035305 Retinal Detachment DisGeNET Curated 1.937E-4 5.776E-3 4.332E-2
1.964E-1
 2 59
26 C0280217 stage, non-small cell lung cancer DisGeNET BeFree 2.139E-4 5.776E-3 4.332E-2
2.169E-1
 2 62
27 C1449563 Cardiomyopathy, Familial Idiopathic DisGeNET Curated 2.155E-4 5.776E-3 4.332E-2
2.185E-1
 3 365
28 C0154830 Proliferative diabetic retinopathy DisGeNET BeFree 2.280E-4 5.776E-3 4.332E-2
2.312E-1
 2 64
29 C1510885 Angiogenic Switch DisGeNET BeFree 3.049E-4 5.776E-3 4.332E-2
3.092E-1
 2 74
30 C0152025 Polyneuropathy DisGeNET Curated 3.302E-4 5.776E-3 4.332E-2
3.348E-1
 2 77
31 C0027765 nervous system disorder DisGeNET Curated 3.331E-4 5.776E-3 4.332E-2
3.377E-1
 3 423
32 C0030297 Pancreatic Neoplasm DisGeNET Curated 3.642E-4 5.776E-3 4.332E-2
3.693E-1
 3 436
33 C0018923 Hemangiosarcoma DisGeNET Curated 3.654E-4 5.776E-3 4.332E-2
3.705E-1
 2 81
34 OMIN:612954 MYOPATHY, MYOFIBRILLAR, BAG3-RELATED OMIM 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
35 C0263560 Chronic ulcer of lower extremity DisGeNET BeFree 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
36 C1970461 Externally rotated/abducted legs DisGeNET Curated 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
37 cv:C3151433 Osteogenesis imperfecta type 12 Clinical Variations 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
38 C0041295 Tuberculoma DisGeNET BeFree 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
39 C0085388 Intracranial Tuberculoma DisGeNET BeFree 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
40 C1337035 Xanthogranulomatous cholecystitis DisGeNET BeFree 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
41 C0730284 Clinically significant macular edema DisGeNET BeFree 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
42 C0333419 Sarcoid type granuloma DisGeNET BeFree 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
43 C0221025 Kasabach-Merritt syndrome DisGeNET BeFree 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
44 cv:C3151293 Dilated cardiomyopathy 1HH Clinical Variations 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
45 C0238309 Ischemic peripheral neuropathy DisGeNET BeFree 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
46 C0265905 Agenesis of pulmonary artery DisGeNET Curated 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
47 cv:C2751831 Myofibrillar myopathy, BAG3-related Clinical Variations 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
48 C0025349 Menstruation, Retrograde DisGeNET BeFree 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
49 C0334400 Sclerosing stromal tumor DisGeNET BeFree 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
50 C0266782 Abnormal yolk sac DisGeNET BeFree 3.703E-4 5.776E-3 4.332E-2
3.754E-1
 1 1
Show 45 more annotations